Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia

This study has been terminated.
(Slow recruitment, high drop-out rate in both arms)
Sponsor:
Collaborator:
National Alliance for Research on Schizophrenia and Depression
Information provided by:
State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier:
NCT00727103
First received: July 28, 2008
Last updated: June 2, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):